Veracyte reported $59.54M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Agenus AGEN:US $ 21.38M 4.73M
Anika Therapeutics ANIK:US $ 17.5M 489K
Biocept BIOC:US $ 5.37M 177.24K
Bruker BRKR:US $ 141.3M 6.6M
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Exact Sciences EXAS:US $ 383.16M 20.7M
Genmark Diagnostics GNMK:US $ 12.4M 2.06M
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Illumina ILMN:US $ 813M 400M
Immunogen IMGN:US $ 10.3M 569K
Intrexon XON:US $ 18.66M 1.34M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Laboratory Of America LH:US $ 519.9M 73.2M
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Luminex LMNX:US $ 36.18M 1.04M
Myriad Genetics MYGN:US $ 180.2M 45.4M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Siemens SIE:GR 3.23B 288M
Sonic Healthcare SHL:AU $ 2B 41.07M
Thermo Fisher Scientific TMO:US $ 1.73B 214M
Veracyte VCYT:US $ 59.54M 39.63M
Waters WAT:US $ 152.54M 5.67M